Sign in
4

Changes in Ownership

bioAffinity Technologies, Inc. Filed Acc 0001493152-22-033370

EVP, Chief Sci. & Med. Officer acquired 7,239 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rebel Vivienne I EVP, Chief Sci. & Med. Officer 2022-11-17 Grant or award +7,239 14,381 D
Loading xslF345X03/ownership.xml…